Respira Therapeutics
is headquartered in Albuquerque, New Mexico. Respira Therapeutics's latest funding round was a Debt - PPP (CARES Act) for $150K on Apr 2020. Respira Therapeutics's main competitors are Qnovia, Aerami and Avalyn Pharma. Respira Therapeutics has 7 followers on Owler. Respira Therapeutics has an estimated revenue of <$1M and an estimate of less <10 employees.Respira Therapeutics
is headquartered in Albuquerque, New Mexico. Respira Therapeutics's latest funding round was a Debt - PPP (CARES Act) for $150K on Apr 2020. Respira Therapeutics's main competitors are Qnovia, Aerami and Avalyn Pharma. Respira Therapeutics has 7 followers on Owler. Respira Therapeutics has an estimated revenue of <$1M and an estimate of less <10 employees.
CEO
Add
News
Apr 05, 2022
OINDPnews
Respira Therapeutics: Respira initiates Phase 2b trial of RT234 inhaled vardenafil for PAH
Oct 27, 2018
BioPortfolio
Respira Therapeutics: Respira Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250
Jul 30, 2018
BioPortfolio
Respira Therapeutics: Respira Therapeutics Inc Medical Equipment Deals and Alliances Profile Report Updated 12062018 Prices from USD $250
Mar 25, 2018
BioPortfolio
Respira Therapeutics: Respira Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14032018 Prices from USD $250
Dec 14, 2017
BioPortfolio
Respira Therapeutics: Respira Therapeutics Inc Medical Equipment Deals and Alliances Profile Report Updated 08112017 Prices from USD $250
Dec 08, 2017
BioPortfolio
Respira Therapeutics: Respira Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 08112017 Prices from USD $250
Jul 25, 2017
BioPortfolio
Respira Therapeutics: Respira Therapeutics Inc Medical Equipment Deals and Alliances Profile. Report Updated 20072017 Prices from USD $250
Jul 20, 2017
The Business Journals
Respira Therapeutics: This startup raised the most funding in NM for Q2, according to report
Apr 13, 2017
BioPortfolio
Respira Therapeutics: Therapeutics Firms to Collaborate on Inhaled Drug Delivery for Hypertension
Apr 11, 2017
Newswise
Press Release: Respira Therapeutics : Respira Therapeutics Announces Collaboration with United Therapeutics to Treat Pulmonary Hypertension
Respira Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10